ArticleBMC psychiatry2026
Management of suicidal crisis in an adolescent with Becker muscular dystrophy: a case report.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBecker muscular dystrophy (BMD) is a rare X-linked recessive disorder associated with progressive physical disability, which may increase the risk of suicidal ideation. However, acute suicidal crises are rarely reported in BMD, as neuromuscular vulnerability restricts standard emergency pharmacological and somatic interventions. We describe an adolescent with BMD complicated by severe suicidal crisis to highlight key diagnostic and therapeutic considerations. CASE PRESENTATION: A 16-year-old boy, who was diagnosed with BMD at the age of 8, became socially isolated due to progressive muscle weakness and long-term home confinement. He had experienced depressed mood for 3 years and recurrent self-injurious behavior for 6 months before admission, eventually engaging in wrist-cutting and an attempted jump from a building. Psychological assessment revealed severe depression and anxiety. To avoid premature definitive classification during an acute crisis, the patient was managed under a broader working diagnosis of mood disorder. Treatment emphasized psychotherapy and family intervention, with adjunctive low-dose fluoxetine (20 mg/day) and olanzapine (5 mg/day) to control impulsivity while minimizing sedation-related worsening of muscle weakness. Suicidal ideation resolved within 5 days, and no further severe suicidal behavior occurred over 10 months of follow-up.
conclusionsSevere suicidal behavior in BMD highlights the profound psychiatric impact of progressive physical and social decline. In adolescents with BMD and severe suicidal behaviors, dynamic assessment and early crisis intervention are essential. Psychological and family-based interventions should be prioritized, while pharmacotherapy, when needed, should be used cautiously to avoid exacerbating underlying neuromuscular weakness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.